Juvenile pig detrusor: Effects of propiverine and three of its metabolites

European Journal of Pharmacology

Volumn 524, Issue 1-3, 2005, Pages 145-148

  Wuest, Melinda ^a,c   Braeter, Manfred ^b   Schoeberl, Christian ^b   Ravens, Ursula ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b APOGEPHA Arzneimittel GmbH   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Detrusor contraction; Juvenile pig; Propiverine and metabolites

Indexed keywords

2,2 DIPHENYL 2 HYDROXYACETIC ACID(1 METHYLPIPERID 4 YL)ESTER N OXIDE; 2,2 DIPHENYL 2 PROPOXYACETIC ACID(1 METHYLPIPERID 4 YL)ESTER N OXIDE; 2,2 DIPHENYL 2 PROPOXYACETIC ACID(PIPERID 4 YL)ESTER; ATROPINE; DRUG METABOLITE; PROPIVERINE; TETRODOTOXIN; TOLTERODINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ELECTROSTIMULATION; FEMALE; JUVENILE; MALE; MATURATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION;

ANIMALS; ATROPINE; BENZHYDRYL COMPOUNDS; BENZILATES; CARBACHOL; CRESOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; PARASYMPATHOLYTICS; PHENYLPROPANOLAMINE; SWINE; TETRODOTOXIN; URINARY BLADDER;

EID: 27744482478     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.09.040     Document Type: Article

References (15)

1. K.E. Andersson, and M. Yoshida Antimuscarinics and the overactive detrusor - which is the main mechanism of action? Eur. Urol. 43 2003 1 5
2. K.E. Andersson, R. Appell, L.D. Cardozo, C. Chapple, H.P. Drutz, A.E. Finkbeiner, F. Haab, and R. Vela Navarrete The pharmacological treatment of urinary incontinence BJU Int. 84 1999 923 947
3. K.E. Andersson, R. Appell, S. Awad, C. Chapple, H.P. Drutz, A.E. Finkbeiner, J. Fourcroy, F. Haab, and A. Wein Pharmacological treatment of urinary incontinence P. Abrams L. Cardozo S. Khoury A. Wein Incontinence, 2nd International Consultation on Incontinence 2002 Health Publisher Limited Plybridge, UK 1898452555 481 511
4. A. Haruno Inhibitory effects of propiverine hydrochloride on the agonist-induced or spontaneous contractions of various isolated muscle preparations Arzneim.-Forsch./Drug Res. 42 1992 815 817
5. K.O. Haustein, and G. Hüller On the pharmacokinetics and metabolism of propiverine in man Eur. J. Drug Metab. Pharmacokinet. 13 1988 81 90
6. P. Longhurst Developmental aspects of bladder function Scand. J. Urol. Nephrol. 215 2004 11 19 (Suppl.)
7. H. Madersbacher, and G. Mürtz Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic) World J. Urol. 19 2001 324 335
8. A.-D. Marschall-Kehrel, G. Mürtz, G. Kramer, K.-P. Jünemann, and H. Madersbacher An empirical treatment algorithm for incontinent children J. Urol. 171 2004 2667 2671
9. J.G. Ouslander Management of overactive bladder N. Engl. J. Med. 350 2004 786 799
10. D.J. Sellers, C.R. Chapple, and R. Chess-Williams Potential therapeutic targets for treatment of the overactive bladder World J. Urol. 19 2001 307 311
11. G.N. Sibley A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit J. Physiol. 354 1984 431 443
12. H. Tokuno, J.U. Chowdhury, and T. Tomita Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle Naunyn-Schmiedeberg's Arch. Pharmacol. 348 1993 659 662
13. Y. Wada, M. Yoshida, K. Kitani, H. Kikukawa, A. Ichinose, W. Takahashi, S. Gotoh, A. Inadome, J. Machida, and S. Ueda Comparison of the effects of anticholinergic drugs on human isolated urinary bladder Arch. Int. Pharmacodyn. 330 1995 76 79
14. M. Wuest, B. Averbeck, S. Reif, M. Bräter, and U. Ravens Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse Eur. J. Pharmacol. 454 2002 59 69
15. M. Wuest, J. Hecht, T. Christ, M. Braeter, C. Schoeberl, O.W. Hakenberg, M.P. Wirth, and U. Ravens Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction Br. J. Pharmacol. 145 2005 608 619